Michigan Medicine earns accreditation from Adult Congenital Heart Association
In recognition of its expertise in serving adults with congenital heart disease (CHD), Michigan Medicine has received accreditation from the Adult Congenital Heart Association (ACHA).
The ACHA, a nationwide organization focused on connecting patients, family members and health care providers to form a community of support and network of experts with knowledge of congenital heart disease, is launching its national accreditation program with 11 centers across the U.S.
Individuals with CHD, the most common birth defect diagnosed in one in every 100 births, are living longer. There are now 1.4 million adults in the U.S. living with one of the many different types of congenital heart defects that range among simple, moderate and complex.
“We are excited to be among the first ACHD programs in the country to earn accreditation from the Adult Congenital Heart Association,” said Timothy Cotts, M.D., cardiologist and director of Michigan Medicine’s adult congenital heart disease program. “Accreditation status is reflective of the great cooperation at Michigan Medicine between adult and pediatric cardiology, our commitment to patient and family centered care, and the strength of other programs such as maternal fetal medicine.”
Michigan Medicine received accreditation by meeting ACHA’s criteria, which includes medical services and personnel requirements, and going through a rigorous accreditation process, both of which were developed over a number of years through a collaboration with doctors, physician assistants, nurse practitioners, nurses and ACHD patients.
“There are now more adults than children in the U.S. with CHD,” said Mark Roeder, president and CEO of ACHA. “Accreditation will elevate the standard of care and have a positive impact on the futures of those living with this disease. Coordination of care is key, and this accreditation program will make care more streamlined for ACHD patients, improving their quality of life.”